Causal associations between major depressive disorder and COVID-19
Ancha Baranova1,2, Yi Zhao3, Hongbao Cao1
1School of Systems Biology, George Mason University, Fairfax, Virginia, USA.
Insights
Major depressive disorder (MDD) increases susceptibility to COVID-19, but COVID-19 does not causally affect MDD. This highlights the need for mental health support during pandemics.
Area of Science:
- Psychiatry
- Infectious Diseases
- Genetics
Background:
- Investigating the bidirectional relationship between major depressive disorder (MDD) and coronavirus disease 2019 (COVID-19).
- Examining if MDD exacerbates COVID-19 outcomes or if genetic predisposition to COVID-19 triggers MDD.
Purpose of the Study:
- To assess bidirectional causal associations between MDD and COVID-19.
- To explore potential genetic and molecular links between these conditions.
Main Methods:
- Utilized genetic correlation and Mendelian randomization (MR) analyses for association assessment.
- Conducted literature-based network analysis to identify molecular pathways connecting MDD and COVID-19.
Main Results:
- MDD showed positive genetic correlations with COVID-19 outcomes (rg: 0.10-0.15).
- Genetic liability to MDD was linked to increased COVID-19 infection risk (OR=1.05, 95% CI: 1.00-1.10).
- No causal effect of COVID-19 genetic liability on MDD was found; immunity-related genes may mediate the link.
Conclusions:
- MDD may increase susceptibility to COVID-19.
- Emphasizes the need for enhanced social support and mental health interventions for individuals with mood disorders during pandemics.
Background:
We aimed to evaluate whether major depressive disorder (MDD) could aggravate the outcomes of coronavirus disease 2019 (COVID-19) or whether the genetic liability to COVID-19 could trigger MDD.
Aims:
We aimed to assess bidirectional causal associations between MDD and COVID-19.
Methods:
We performed genetic correlation and Mendelian randomisation (MR) analyses to assess potential associations between MDD and three COVID-19 outcomes. Literature-based network analysis was conducted to construct molecular pathways connecting MDD and COVID-19.
Results:
We found that MDD has positive genetic correlations with COVID-19 outcomes (rg: 0.10-0.15). Our MR analysis indicated that genetic liability to MDD is associated with increased risks of COVID-19 infection (odds ratio (OR)=1.05, 95% confidence interval (CI): 1.00 to 1.10, p=0.039). However, genetic liability to the three COVID-19 outcomes did not confer any causal effects on MDD. Pathway analysis identified a panel of immunity-related genes that may mediate the links between MDD and COVID-19.
Conclusions:
Our study suggests that MDD may increase the susceptibility to COVID-19. Our findings emphasise the need to increase social support and improve mental health intervention networks for people with mood disorders during the pandemic.
Related Concept Videos
Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Depression: Overview
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Causality in Epidemiology
Depressive Disorders: MDD and Dysthymia


